<DOC>
	<DOCNO>NCT01633983</DOCNO>
	<brief_summary>Central serous chorioretinopathy ( CSC ) disease unknown origin however multiple report indicate correlation appearance CSC exposure exogenous elevate level endogenous corticosteroid . Since level endogenous corticosteroid upregulated many inflammatory condition , control inflammation may beneficial reduce level thus eliminate stimulus CSC . Methotrexate ( MTX ) widely use control different type inflammation . The investigator go try escalate dos MTX treat CSC full medical supervision .</brief_summary>
	<brief_title>Methotrexate Central Serous Chorioretinopathy Treatment Trial</brief_title>
	<detailed_description>Central serous chorioretinopathy ( CSC ) disease unknown origin usually affect center macula adult work age . Though previously condition consider stress-related , multiple recent report indicate correlation appearance CSC exposure exogenous elevate level endogenous corticosteroid . Since level endogenous corticosteroid upregulated many inflammatory condition , control inflammation may downregulate endogenous steroid thus eliminate stimulus CSC . Methotrexate ( MTX ) widely use control different type inflammation . Few short retrospective series beneficial effect MTX CSC report recently . The investigator go try escalate dos MTX treat CSC full medical supervision prospective manner .</detailed_description>
	<mesh_term>Central Serous Chorioretinopathy</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<criteria>Central Serous Chorioretinopathy Pregnancy Liver disease Kidney disease Steroid use</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>Central Serous Chorioretinopathy</keyword>
	<keyword>Methotrexate</keyword>
</DOC>